Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  MacHado, Daniel E ^a   Berardo, Plínio T ^a   Palmero, Celia Y ^a   Nasciutti, Luiz E ^a  

^a Inst de Cincias Biomedicas   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; AUTOTRANSPLANTATION; BLOOD VOLUME; CANCER RISK; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MORPHOLOGICAL TRAIT; MORPHOMETRICS; NEOPLASM; NONHUMAN; PERITONEAL CAVITY; PERITONEAL ENDOMETRIOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; STROMA; ANIMAL; DISEASE MODEL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PERITONEAL DISEASE;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; FEMALE; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; PERITONEAL DISEASES; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77449141720     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-4     Document Type: Article

References (41)

1. Clinical presentation and diagnosis of endometriosis. PC Galle, Obstet Gynecol Clin North Am 1989 16 29 42 2664621
2. Epidemiology and prevalence of endometriosis. JM Wheeler, Infertil Reprod Med Clin North Am 1992 3 545 549
3. Endometriosis. LC Giudice LC Kao, Lancet 2004 364 1789 1799 10.1016/S0140-6736(04)17403-5 15541453
4. Vascular development in endometriosis. PG Groothuis AW Nap E Winterhager R Grümmer, Angiogenesis 2005 8 147 156 10.1007/s10456-005-9005-x 16211360
5. Angiogenesis in cancer, vascular, rheumatoid and other disease. J Folkman, Nat Med 1995 1 1 27 31 10.1038/nm0195-27 7584949
6. Angiogenic factors in endometriosis. RN Taylor DI Lebovic MD Mueller, Ann N Y Acad Sci 2002 955 89 100 10.1111/j.1749-6632.2002.tb02769.x 11949968
7. Postmenopasual cancer risk after self-reported endometriosis diagnosis in the Iowa women's health study. JE Olson JR Cerhan CA Janney KE Anderson CM Vachon TA Sellers, Cancer 2002 94 1612 1618 10.1002/cncr.10370 11920519
8. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. A Melin P Sparen A Bergqvist, Hum Reprod 2006 21 1237 1242 10.1093/humrep/dei462 16431901
9. Vasculogenesis and angiogenesis. S Patan, Cancer Treat Res 2004 117 3 32 15015550
10. Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in ectopic and eutopic endometrium. QH Chen JU Qu YY Xu NX Qiu YZ Zhuang S Zhong QQ Fang, Zhonghua Fu Chan Ke Za Zhi 2004 39 809 812 15733405
11. Mechanisms of angiogenesis. W Risau, Nature 1997 386 6626 671 674 10.1038/386671a0 9109485
12. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J McLaren A Prentice DS Charnock-Jones SA Millican KH Müller AM Sharkey, et al. J Clin Invest 1996 98 482 489 10.1172/JCI118815 8755660 (Pubitemid 26255749)
13. Vascular Endothelial Growth Factor concentrations in the serum and peritoneal fluid of women with endometriosis. A Pupo-Nogueira RM de Oliveira CA Petta S Podgaec JÁ Dias MS Abro, Int J Gynecol Obstet 2007 99 1 33 37 10.1016/j.ijgo.2007.04.033 (Pubitemid 47347999)
14. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. N Ferrara, Am J Physiol Cell Physiol 2001 280 1358 1366
15. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. V Bourlev N Volkov S Pavlovitch N Lets A Larsson M Olovsson, Reproduction 2006 132 3 501 509 10.1530/rep.1.01110 16940291
16. Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. DE Machado MS Abro PT Berardo CM Takiya LE Nasciutti, Fertil Steril 2008 90 1 148 155 10.1016/j.fertnstert.2007.05.076 17765237
17. Animals models in endometriosis research. R Grümmer, Hum Reprod Update 2006 5 12 641 649 10.1093/humupd/dml026 (Pubitemid 44288713)
18. Studies on the surgical induction of endometriosis in the rat. MW Vernon EA Wilson, Fertil Steril 1985 44 5 684 694 4054348
19. Antiangiogenesis therapy for endometriosis. AW Nap AW Griffioen GA Dunselman JC Bouma-Ter VL Thijssen JL Evers, et al. J Clin Endocrinol Metab 2004 89 1089 1095 10.1210/jc.2003-031406 15001592
20. Vascular endothelial growth factor in endometriosis. J Donnez P Smoes S Gillerot F Casanas-Roux M Nisolle, Hum Reprod 1998 13 1686 1690 10.1093/humrep/13.6.1686 9688413
21. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. JA Sampson, Am J Obstet Gynecol 1927 14 422 469
22. Pathogenesis of endometriosis. AW Nap PG Groothuis AY Demir JL Evers GA Dunselman, Bet Pract Res Clin Obstet Gynaecol 2004 18 233 244 10.1016/j.bpobgyn.2004.01.005 (Pubitemid 38786630)
23. Endometriosis and the outcome of in vitro fertilization. I Brosens, Fertil Steril 2004 81 1198 1200 10.1016/j.fertnstert.2003.09.071 15136075
24. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. DI Lebovic M Kir CL Casey, Fertil Steril 2004 82 3 1008 1013 10.1016/j.fertnstert.2004.02.148 15474065
25. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. E Dogan U Saygili C Posaci B Tuna S Caliskan S Altunyurt B Saatli, Fertil Steril 2004 82 3 1115 1120 10.1016/j.fertnstert.2004.06.033 15474083
26. Immunological aspects of endometriosis. D Vinatier P Dufour D Oosterlynck, Hum Reprod Update 1996 2 5 371 384 10.1093/humupd/2.5.371 15717437
27. Angiogenesis and antiangiogenesis therapy in endometriosis. CM Backer RJ D'Amato, Microvas Res 2007 74 121 130 10.1016/j.mvr.2007.04.008 (Pubitemid 350051024)
28. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. MD Mueller DI Lebovic E Garrett RN Taylor, Fertil Steril 2000 74 1 107 112 10.1016/S0015-0282(00) 00555-0 10899506
29. Expression of vascular endothelial growth factor receptors in the ectopic and eutopic endometrium of women with endometriosis. HB Wang JH Lang JH Leng L Zhu ZF Liu DW Sun, Zhonghua Yi Xue Za Zhi 2005 85 22 1555 1559 16179118
30. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. YJ Lin MD Lai HY Lei LY Wing, Endocrinology 2006 147 3 1278 1286 10.1210/en.2005-0790 16306083
31. Tumor angiogenesis: therapeutic implications. J Folkman, New Engl J Med 1971 285 21 1182 1186 4938153
32. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. AH Prowse S Manek R Varma J Liu AK Godwin ER Maher IPM Tomlinson SH Kennedy, Int J Cancer 2006 119 556 562 10.1002/ijc.21845 16506222
33. The risk of cancer and the role of parity among women with endometriosis. A Melin P Sparen A Berqvist, Hum Reprod 2007 22 3021 3026 10.1093/humrep/dem209 17855408
34. Endometriosis: Pathogenesis, diagnosis, therapy and association with cancer. A Baldi M Campioni PG Signorile, Oncol Reports 2008 19 843 846
35. Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis. AG Goumenou DA Arvanitis IM Matalliotakis EE Koumantakis DA Spandidos, Fertil Steril 2001 75 160 165 10.1016/S0015-0282(00)01663-0 11163832
36. Involvement of the ras genes in female genital tract cancer. IN Mammas A Zafiropoulos DA Spandidos, Int J Oncol 2005 26 1241 1255 15809715
37. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. HW Chung Y Wen SH Chun C Nezhat BH Woo PM Lake, Fertil Steril 2001 75 1 152 159 10.1016/S0015-0282(00)01670-8 11163831
38. 15-Epi-lipoxin A(4) inhibits the progression of endometriosis in a murine model. QH Chen WD Zhou DM Pu QS Huang T Li QX Chen, Fertil Steril 2009
39. Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation. CB Kirn-Safran SS D'Souza DD Carson, Semin Cell Dev Biol 2008 19 187 193 10.1016/j.semcdb.2007.07.013 17766150
40. Composition of sulfated glycosaminoglycans and immunodistribution of chondroitin sulfate in deeply infiltrating endometriosis affecting the rectosigmoid. PT Berardo MS Abro ML Souza DE Machado LC Silva LE Nasciutti, Micron 2009 40 639 45 10.1016/j.micron.2009.02.005 19278856
41. Distribution of chondroitin sulfate in human endometrium. LE Nasciutti R Ferrari PT Berardo MLS Souza CM Takiya R Borojevic MS Abrao LCF Silva, Micron 2006 37 544 550 10.1016/j.micron.2005.12.005 16458524